"closely associated" drug development by press release analysis

Ended Awarded Last action

Contract number
HHSF22312002
Awardee
Awarding agency
Obligated
$55,141

Award facts

Contract value 17% obligated
  • $55,141.39 Current, with exercised options
  • $333,035.39 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541611 Administrative Management and General Management Consulting Services
PSC
B528 Special Studies/Analysis- Regulatory
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates
  • Other statutory authority

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 2 -$83,806
Other Administrative Action 1 · Study titled: drug development by press release analysis $0
Original award $138,947

Quick answers

Who was awarded contract HHSF22312002?

HHSF22312002 was awarded to Eastern Research Group Inc. by Food and Drug Administration (Department of Health and Human Services) on August 20, 2012.

How much is contract HHSF22312002 worth?

The government has obligated $55,141 on HHSF22312002. Its potential value, with all options, is $333,035.

Is contract HHSF22312002 an order under another contract?

Yes. HHSF22312002 is a BPA call under GS10F0125P-HHSF223201110018B, a blanket purchase agreement, on Mission Oriented Business Integrated Services (MOBIS).

Was contract HHSF22312002 competed?

The extent of competition for HHSF22312002 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award